Becker's Healthcare February 24, 2025
A meeting held between President Donald Trump and top pharmaceutical executives showed some tensions over drug pricing policy, tariffs and manufacturing.
Here are four notes:
- In a private White House meeting Feb. 20, President Trump warned drugmakers that tariffs on pharmaceuticals could be imminent and urged companies to shift overseas manufacturing to the U.S., Bloomberg reported Feb. 21.
- President Trump did not commit to supporting the pharmaceutical industry’s push to scale back the drug pricing negotiation program enacted under Joe Biden, and executives have been seeking relief from the policy.
- During the meeting, top executives from Eli Lilly, Merck, Pfizer and PhRMA urged President...
Today's Sponsors
Today's Sponsor